Dr. Agarwal’s Eye Hospital ₹3.50 Final Dividend for FY25 Record Date is Tomorrow, Sept 18

Dr. Agarwal’s Eye Hospital Limited has announced a final dividend of ₹3.50 per equity share of ₹10 each (35%) for the financial year 2024-25. 

This recommendation, made by the Board on May 28, 2025, is subject to shareholder approval at the company’s upcoming Annual General Meeting (AGM), which is to be held on Wednesday, September 24, 2025.

Record Date and Payment Timeline

The company has fixed Thursday, September 18, 2025, as the record date to determine the eligibility of shareholders for the dividend. Upon approval at the AGM, the dividend will be credited or paid on or before October 24, 2025, to shareholders whose names appear on the Register of Members and Beneficial Owners list as provided by the Depositories.

For shareholders, the dividend can provide steady returns and underlines the company’s confidence in its growth trajectory. For example, an investor holding 1,000 shares will receive a dividend payout of ₹3,500 for FY25, subject to approval.

Previous Dividend History

Dr. Agarwal’s Eye Hospital has consistently rewarded its investors. The company declared an interim dividend of ₹2.50 per share in November 2024 and a final dividend of ₹2.50 per share in August 2024.

Also Read: Dividends & Bonus Issue This Week (Sept 15–19, 2025)!

Conclusion

The final dividend announcement further strengthens Dr. Agarwal’s Eye Hospital’s reputation for shareholder-friendly policies. With a record of payouts and business growth, the company continues to deliver long-term value. Shareholders must hold shares in a valid demat account as of the record date to be eligible for the dividend.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.